Speed and accuracy are critical in drug development ... intelligence (AI) with deep learning and ‘omics’ analyses to discover novel, therapeutic and commercial food-derived peptides.

Researchers from Stanford Medicine have discovered a naturally occurring molecule that may provide an alternative to the ...

“There is great need to revolutionize the current inefficient drug discovery and development process, reducing time, cost and risk.” Pepticom, a pioneer in AI-driven peptide drug discovery and ...

Prior research has suggested that drug-resistant ... developing or finding peptides has proven to be too slow to address the crisis. So researchers have turned to AI-based approaches to aid ...

In a study published in Science, a research team led by Prof. Ye Jian from the Institute of Microbiology of the Chinese ...

DiaGen Ai Inc. Announces its Selection as a Top 100 Canadian Tech Company VANCOUVER, BC, CANADA, April 11, 2025 /EINPresswire / -- DiaGen Ai I ...

Elix Inc. has entered into a drug discovery collaboration with Prism Biolab Co. Ltd. to accelerate AI-driven drug discovery for challenging protein-protein interaction targets. The partnership will ...

Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the company inked with Austria-based drug delivery technology maker Cyprumed.

Attempts over the years to design "small molecule" drugs that block them have been largely unsuccessful, so in recent years scientists have explored using peptides – small protein fragments ...

told Purdue researchers that Lilly is "using AI not just in augmenting human capabilities, but in drug discovery, clinical trials, process optimization and data integration." On Feb. 13 ...

So, too, is the vast, unexplored drug-hunting territory of chemical space, waiting to be illuminated by data’s light. Every AI model trained for biology only can see what’s illuminated by the ...